…discovery approach across multiple diseases, AI-based disease modeling, an
Neurodegenerative diseases
51 results
Upcoming first, then newest
Expanding mechanisms and therapeutic targets for neurodegenerative disease
A hallmark pathological feature of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the depletion of RNA-binding protein TDP-43 from the nucleus of neurons in the brain and spinal cord. A major function of TDP-43 is as a repressor of cryptic exon inclusion during RNA splicing. By re-analyzing RNA-sequencing datasets from human FTD/ALS brains, we discovered dozens of novel cryptic splicing events in important neuronal genes. Single nucleotide polymorphisms in UNC13A are among the strongest hits associated with FTD and ALS in human genome-wi
Thu, Jun 5, 2025 · 14:00 UTC
Genetic and epigenetic underpinnings of neurodegenerative disorders
…and epigenetic underpinnings of human diseases such as Parkinson’s, Alzheimer’s, autism, and cancer. Mechanisms of somatic cell reprogramming to an embryonic pluripotent state are explored, utilizing patient-specific pluripotent cells to model and analyze neurodegenerative diseases.
Wed, Dec 11, 2024 · 12:15 UTC
Bistability at the cellular level promotes robust and tunable criticality at the circuit level
For more than 20 years, a growing body of evidence indicates that the brain functions near a critical point, where neural activity is balanced between damping and amplification. One of the appealing benefits of criticality is its optimal information processing [1, 2]. In addition, deviations from criticality are associated with age and disease [3] but also physiological state [4]. Yet the neural mechanisms involved in maintaining and/or altering this criticality remain unclear. To investigate how cellular mechanisms can influence criticality, we analyze a model of neuronal network [5] and quan
BrainVector: A comprehensive platform for pre-clinical development of AAV-based gene therapies for brain diseases
…strategy for a wide range of neurodegenerative diseases. Adeno-associated viruses (AAVs) have demonstrated significant potential as safe and effective vectors for the delivery of therapeutic genes to the CNS. Despite the tremendous promises of AAV-based gene therapies, the pathway to develop these therapies from bench to clinic remains complex and arduous. In response to these challenges, we introduce the BrainVector project, a comprehensive cross-disciplinary platform that streamlines the pre-clinical development of AAV-bas
Cell- and layer-type specific intracortical effects of pulsed and continuous wave infrared neural stimulation revealed by high-density laminar recordings in the rat neocortex
…of IR inhibition in the treatment of neurodegenerative diseases such as epilepsy underscores the importance of further elucidating its biophysical mechanism. In this study, the effects of IR neuromodulation on cortical neurons in vivo were investigated using high-density laminar recordings. The neocortex of anesthetized rats was exposed
Cellular and molecular footprint of aging in a defined neuronal network encoding associative memory
…age-related memory impairment, and neurodegenerative diseases of vertebrates including humans. Using young (3-4
Characterization of exosomes isolated from glioblastoma (U-87) cells and their use as prophylactic in Alzheimer's disease
…application against AD and similar neurodegenerative diseases. Exosomes are small particles that can cross biological membranes like the blood-brain barrier. They are being used as drug carrier systems and have attracted attention recently. In AD and similar diseases, exposure to oxidant molecules increases in
Chimeric in vitro model to study human microglia
Studying the dynamic role of microglia in brain development and neurodegenerative diseases requires models that closely resemble the human brain environment. While murine models provide valuable insights, they often have important transcriptional and cellular differences from humans. Addressing this, we developed a chimeric in vitro model to study microglial behavior within a human-like neuronal setting.We co-cultured human iPSC-derived human organoids (hORG) with mouse brain slice cultures (mBSC). In this chimeric setup we found multiple interactions between mouse and human tissue, markedly a
Compensation by dynamics: Functional connectivity rescued from structural damage by modulating dynamical regime
Aging and neurodegenerative diseases, such as Alzheimer's (AD) or Amyotrophic Lateral Sclerosis (ALS), led to widespread degeneration of long-range connections in cortical structural connectivity (SC). These damages manifest as losses in connections or demyelination of axons. When the SC of the brain is damaged, the functional connectivity (FC, i.e. the dynamic interactions and information exchange between distinct brain regions) is locally and globally perturbed. Despite the close correlation between SC and FC, they are not identical; FC exhibits greater flexibility and can reorganize in resp
Design and development of nanoliposomes based on soy lecithin for the delivery of molecules to the CNS as strategy for the treatment of neurodegenerative diseases
…to the brain for the treatment of neurodegenerative diseases is a great challenge because of the blood-brain barrier selectivity. However, nanoliposomal systems can provide an alternative to this drawback. This study aimed to design and develop nanoliposomes based on soy lecithin loaded with galantamine (acetylcholinesterase inhibitor) or DNA aptamers designed to hinder the aggregation of proteins like Aβ, TDP-43 and α-synuclein. For this, a complete physicochemical characterization of soy lecithin and other raw materials was carried
Development of a microfluidic device to mimic the blood-brain barrier using human iPSC-differentiated cells
…development and progression of many neurodegenerative diseases, such as Alzheimer’s Disease (AD). However, most in vitro BBB models are static, complicating the understanding of disease pathophysiology. With that, our study aims to develop a microfluidic device to better study the relationship between neurodegenerative diseases and the BBB in vitro. The device, printed using polydimethylsiloxane, includes a compartment for a hydrogel containing neurons and astrocytes to mimic cerebral parenchyma and a m
Dietary restriction during adolescence improves the memory performance of old female Wistar rats in an onset- and duration-dependent manner
…abilities are a major risk factor for neurodegenerative diseases. Dietary restriction (DR) can slow or postpone these changes, improving memory, learning, and cognitive abilities, but may not always yield positive results. In this study, we examined the impact of 30% DR (70% of ad libitum daily intake) during adolescence on the short-term (STM) and long-term (LTM) memory performance in 6- and 18-month-old female Wistar rats. The effects of DR were examined in three onsets and durations: DR1 (28th to 35th day of life), DR2 (35th to 42nd day
DREAM protein inhibition as a potential treatment against NAFLD and metabolic syndrome and its associated neurologic signs in mice
…is a risk factor in the development of neurodegenerative diseases, neuropsychiatric disorders and is associated with cognitive decline. DREAM/kchip3/calsenilin (DREAM) is a multifunctional protein that belongs to the neuronal Ca2+ sensor family. Previous studies have demonstrated the relevance of DREAM in nociception and in learning and memor
Early onset of tau pathology in the olfactory system of PS19 mice: A pathway for the progression of tauopathy in the central nervous system
Clinical data strongly support olfactory impairment as an early indicator of neurodegenerative diseases (ND), including Alzheimer’s disease. In AD patients, neurofibrillary tangles (NFTs) have been identified in the entorhinal cortex and olfactory bulbs, both crucial in olfactory information processing. We therefore investigated the hypothesis that typical ND lesions could appear early in olfactory system regions.We used a tauopathy mouse model (PS19 mice) expressing the human tau protein (1N4R) carrying the P301S mutation. PS19 mice develop NFTs-like inclusions at six months, leading to progr
Effects of VRK1 deficiency on the neurophysiology and behavior of zebrafish
…in humans have been linked to several neurodegenerative diseases, including spinal muscular atrophy associated with microcephaly and impaired cognitive and motor function. Thus, it has been identified as potentially involved in the maintenance and development of the nervous system. However, precise pathophysiological mechanisms and VRK1 involvement in cognitive and motor dysfunction progression have yet to
Evidence for a role for alpha oscillations in strategic monitoring underlying prospective remembering
…commonly occur in normal aging and neurodegenerative diseases, highlighting the importance of understanding the underlying mechanisms to inform potential interventions. Brain regions active during PM tasks include the left dorsolateral prefrontal cortex (DLPFC) and inferior parietal cortex. PM tasks engage attentional networks, and changes in alpha frequency oscillations were observed during PM processing. We hypothesized that these
Exploring shared pathways that contribute to both normal brain aging and neurodegenerative disorders
Progressive myoclonus epilepsies (PMEs) represent a group of epilepsy disorders that begin in adolescence and are inherited in an autosomal recessive manner. PME patients exhibit a range of symptoms, including seizures, ataxia, muscle atrophy, dementia, psychosis, and hallucinations. The majority of these subsequent symptoms are likewise observed in older individuals, indicating the potential involvement of the PME genes in the process of aging. A recent study conducted by our group has shown that the expression of PME genes shows an inverse association with age in the normal brain. Since the
Extracellular vesicles from poly I:C-infected airway epithelial cells mediate viral signaling in microglia: Implications for neuroinflammation
Recently found association linking viral infections to neurodegenerative diseases has raised concerns about unknown mechanisms in the communication between the respiratory and central nervous systems . We hypothesized that extracellular vesicles (EVs) can transfer viral signals to microglia, triggering the upregulation of pro-inflammatory cytokines by activating inflammasome-related pathways. In this study, we investigate the role of EVs released from virus mimetic poly I:C-infected human airway epithelial cells in modulating microglial immune responses. EVs were isolated from poly I:C-primed
Immune cell profiling of cerebrospinal fluid in patients with neuroinflammatory diseases using mass cytometry (CyTOF)
…activity for neuroinflammatory and neurodegenerative diseases, such as multiple sclerosis (MS) and Alzheimer´s disease (AD). The CSF is the compartment in closest proximity to the central nervous system (CNS) with unique immune cell composition and routine CSF collection is integral for diagnosing various CNS disorders, offering a more practical alternative to assess the CNS. In this study, we described an end-to-end workflow to perform in-depth single-
The influence of the time of the day on the coupling between global grey matter BOLD and CSF flow signal in healthy humans: Preliminary results
…a decisive role in the pathology of neurodegenerative diseases, hence its relevance for investigation. Novel fMRI tools, e.g., the correlation between global grey matter (gGM) BOLD and CSF flow signal, have enabled neuroimaging researchers to study the system’s function. Yet, no studies are looking at whe
New insights into the neuroprotective effects of anti-diabetic drugs using a mouse model of prion disease
Metabolic disorders like diabetes and obesity markedly elevate the risk of neurodegenerative diseases. While certain medications used to manage these conditions show neuroprotective potential, their exact mechanisms of action remain elusive. Here, we propose the utilization of brain histology in a mouse prion model as an effective approach for drug screening in dementia and for exploring the cellular mechanisms of neuroprotection offered by anti-diabetic drugs. Our primary objective was to establish the morphological criteria for brain pathology in prion-infected mice. To achieve this, C57BL/6
Integrated electrophysiology and fiber photometry examination of the prefrontal cortex in the mouse model of implicit learning
…like Alzheimer’s and Parkinson’s diseases. While the role of neuromodulators in explicit learning is increasingly in the focus of the research, their participation in implicit learning and memory processes is poorly understood.To examine this we have used a previously developed automated training setup in which animals must respond to sequential light flashes at different locations. Following the
Investigating the AMPK-MFF pathway to modulate mitochondrial dynamics as a target for neuroprotection
Cellular hallmarks of neurodegenerative diseases include loss of synapses, neuronal death, inflammation, energy homeostasis defects, oxidative stress, mitochondrial dysfunction, and aberrant proteostasis. AMP-activated kinase (AMPK) maintains energy homeostasis by responding to fluctuating ATP levels, with diverse targets ranging from changing the transcriptional program, promoting glucose uptake, inhibiting protein synthesis, inducing mitochondrial fission, mitophagy and autophagy. Evidence indicates that AMPK is hyperactivated in Alzheimer’s disease (AD), and amyloid-β (Aβ) can activate AMPK